HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steven Y Hua Selected Research

cendakimab

1/2021Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steven Y Hua Research Topics

Disease

2Neoplasms (Cancer)
01/2020 - 10/2018
2Rheumatoid Arthritis
01/2018 - 01/2018
2Open-Angle Glaucoma (Glaucoma, Open Angle)
10/2008 - 01/2007
2Ocular Hypertension (Glaucoma, Suspect)
10/2008 - 01/2007
1Eosinophilic Esophagitis
01/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021
1Ulcerative Colitis
01/2021
1Infections
01/2021
1Breast Neoplasms (Breast Cancer)
01/2020
1Crohn Disease (Crohn's Disease)
01/2020
1Pneumonia (Pneumonitis)
01/2018
1Injection Site Reaction
01/2018
1Hypersensitivity (Allergy)
01/2018
1Myocardial Infarction
01/2018
1Opportunistic Infections (Opportunistic Infection)
01/2018
1Rheumatic Diseases (Rheumatism)
01/2018
1Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2013
1Glaucoma
06/2008
1Hyperemia
01/2007

Drug/Important Bio-Agent (IBA)

3Immunoconjugates (Immunoconjugate)IBA
01/2020 - 02/2013
2Sphingosine-1-Phosphate ReceptorsIBA
01/2021 - 01/2020
2ozanimodIBA
01/2021 - 01/2020
2Biosimilar PharmaceuticalsIBA
01/2018 - 01/2018
2Methotrexate (Mexate)FDA LinkGeneric
01/2018 - 01/2018
2Biological ProductsIBA
01/2018 - 01/2018
2brinzolamide (Azopt)FDA Link
10/2008 - 06/2008
1Interleukin-13IBA
01/2021
1cendakimabIBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1PF-06650808IBA
01/2020
1Glycoproteins (Glycoprotein)IBA
10/2018
1PF-06410293IBA
01/2018
1C-Reactive ProteinIBA
01/2018
1GP1111IBA
01/2018
1Infliximab (Remicade)FDA Link
01/2018
1Adalimumab (Humira)FDA Link
01/2018
1Inotuzumab OzogamicinIBA
02/2013
1Rituximab (Mabthera)FDA Link
02/2013
1Timolol (Blocadren)FDA LinkGeneric
10/2008
1Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric
01/2007
1Travoprost (Travatan)FDA Link
01/2007

Therapy/Procedure

4Therapeutics
01/2021 - 02/2013